Compare ACETAMINOPHEN (Pain Reliever Extra Strength) and Paracetamol (Panadol) — clinical data, side effects, and patient experiences.
Pain Reliever Extra Strength, APADAZ · Analgesic (Non-Opioid)
How it works
Other agent
Approved for
Panadol, Calpol, Tylenol · Analgesic (Non-Opioid)
How it works
Centrally-acting analgesic and antipyretic. Inhibits COX enzymes in the CNS, reducing prostaglandin synthesis. May also activate descending serotonergic pathways.
Approved for
Estimated frequency (%) based on clinical trial data
No data
No specific warnings
No head-to-head clinical studies found for ACETAMINOPHEN vs Paracetamol.
Both ACETAMINOPHEN and Paracetamol belong to the Analgesic (Non-Opioid) class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients. ACETAMINOPHEN is administered via Oral, whereas Paracetamol uses Topical. Route of administration can affect onset of action and patient adherence.
ACETAMINOPHEN carries 2 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.
Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.